Tinea corporis, tinea cruris, tinea nigra, and piedra

Dermatologic Clinics

Volumn 21, Issue 3, 2003, Pages 395-400

  Gupta, Aditya K ^a,b,d   Chaudhry, Maria ^b   Elewski, Boni ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MEDIPROBE RESEARCH INC   (Canada)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE; AMPHOTERICIN B; BUTENAFINE; CHLORHEXIDINE; CICLOPIROXOLAMINE; CLOTRIMAZOLE; GRISEOFULVIN; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NAFTIFINE; OXICONAZOLE; PETROLATUM; PYRITHIONE ZINC; SELENIUM SULFIDE; SULCONAZOLE; TERBINAFINE; TOLNAFTATE;

ANTIFUNGAL ACTIVITY; DERMATOPHYTE; FUNGUS CULTURE; HUMAN; MYCOLOGY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SKIN DISEASE; SUPERINFECTION; TINEA CORPORIS; TINEA CRURIS; TINEA NIGRA; TINEA PEDIS;

EID: 0042515082     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(03)00031-7     Document Type: Review

References (46)

1. Faergemann J, Mörk NJ, Haglund A, Ödegård A. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris. Br J Dermatol 1997;136:575-7.
2. Hay RJ, Moore M. Mycology. In: Champion RH, Burton JL, Burns DA, Breathnach SM, editors. Textbook of dermatology. 6th edition. United Kingdom: Blackwell Science; 1998. p. 1277-376.
3. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. J Am Acad Dermatol 1996;34:282-6.
4. Kohl TD, Lisney M. Tinea gladiatorum. Sports Med 2000;29:439-47.
5. Sadri MF, Farnaghi F, Danesh-Pazhooh M, Shokoohi A. The frequency of tinea pedis in patients with finea cruris in Tehran, Iran. Mycoses 1998;43:41-4.
6. Ginter G. Microsporum canis infections in children: results of a new oral antifungal therapy. Mycoses 1996;39:265-9.
7. Beller M, Gessner BD. An outbreak of tinea corporis gladiatorum on a high school wrestling team. J Am Acad Dermatol 1994;31:197-201.
8. Martin AG, Kobayashi GS. Superficial fungal infection: dermatophytosis, tinea nigra, piedra. In: Feedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatrick's dermatology in general medicine. 5th edition. USA: McGraw-Hill; 1999. p. 2337-57.
9. Elgart ML, Warren NG. Superficial and deep mycoses. In: Moschella SL, Hurley HJ, editors. Dermatology. 3rd edition. Philadelphia: WB Saunders; 1992. p. 869-941.
10. Terragni L, Marelli MA, Oriani A, Cecca E. Tinea corporis bullosa. Mycoses 1993;36:135-7.
11. Grekin RC, Samlaska CP, Vin-Christian K. Diseases resulting from fungi and yeasts. In: Odon RB, James WD, Berger TG, editors. Andrews' diseases of the skin. 9th edition. Philadelphia: WB Saunders; 2000. p. 358-416.
12. Noble SL, Forbes RC, Stamm PL. Diagnosis and management of common tinea infections. Am Fam Physician 1998;58:163-77.
13. Farag F, Taha M, Halim S. One-week therapy with oral terbinafine in cases of tinea crusis/corporis. B J Dermatol 1994;131:684-6.
14. Bourlond A, Lachapelle JM, Aussems J, Boyden B, Campaert H, Conincx S. Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris. Int J Dermatol 1989;28: 410-2.
15. Fulvicin U/F. In: Repchinsky C, Welbanks L, Bisson R, et al, editors. Compendium of pharmaceuticals and specialties: The Canadian drug reference for health professionals. Toronto: Webcom Limited; 2002. p. 678.
16. Lamisil. In: Repchinsky C, Welbanks L, Bisson R, et al, editors. Compendium of pharmaceuticals and specialties: the Canadian drug reference for health professionals. Toronto: Webcom Limited; 2002. p. 870-2.
17. Sporanox capsules. In: Repchinsky C, Welbanks L, Bisson R, et al, editors. Compendium of pharmaceuticals and specialties: the Canadian drug reference for health professionals. Toronto: Webcom Limited; 2002. p. 1581-3.
18. Montero-Gei F, Perera A. Therapy with fluconazole for tinea corporis, tinea cruris, and tinea pedis. Clin Infect Dis 1992;14(suppl 1):S77-81.
19. Nizerol tablets. In: Repchinsky C, Welbanks L, Bisson R, et al, editors. Compendium of pharmaceuticals and specialties: the Canadian drug reference for health professionals. Toronto: Webcom Limited; 2002. p. 1139-40.
20. Pariser DM, Pariser RJ, Ruoff G, Ray TL. Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and cruris. J Am Acad Dermatol 1994;31:232-4.
21. Lachapelle JM, De Doncker P, Tennstedt D, Cauwenbergh G, Janssen PAJ. Itraconazole compared with griseofulvin in the treatment of tinea corpofis/cruris and tinea pedis/manuum: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. Dermatol 1992; 184:45-50.
22. Nozickova M, Koudelkova V, Kulikova Z, Malina L, Urbanowski S, Silny W. A comparison of the efficacy of oral fluconazole 150 mg/week versus 50 mg/day in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidosis. Int J Dermatol 1998;37: 701-8.
23. Parent D, Decroix J, Heenen M. Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and/or cruris. Dermatology 1994;189: 378-81.
24. Mok WY. Nature and identification of Exophiala werneckii. J Clin Microbiol 1982;16:976-8.
25. Tseng SS, Whittier S, Miller SR, Miller SR, Zalar GL. Bilateral tinea nigra plantaris and tinea nigra plantaris mimicking melanoma. Cutis 1999;64:265-8.
26. Shannon PL, Ramos-Caro FA, Cosgrove BF, Flowers FP. Treatment of tinea nigra with terbinafine. Cutis 1999;64:199-201.
27. Blank H. Tinea nigra: a twenty-year incubation period. J Am Acad Dermatol 1979;1:49-51.
28. Göttlich E, de Hoog GS, Yoshida S, et al. Cell-surface hydrophobicity and lipolysis as essential factors in human tinea nigra. Mycoses 1995;38:489-94.
29. Conant NF, Smith DT, Baker RD, Callaway JL. Tinea nigra palmaris. Manual of clinical mycology. 3rd edition. Philadelphia: WB Saunders; 1971. p. 494-502.
30. Palmer SR, Bass JW, Mandjana Rmandojana R, Wittler RR. Tinea nigra palmaris and plantaris: a black fungus producing black spots on the palms and soles. Pediatr Infect Dis J 1989;8:48-50.
31. Merwin CF. Tinea nigra palmaris: review of literature and case report. Pediatrics 1965;36:537-41.
32. Gupta G, Burdern AD, Shankland GS, Fallowfield ME, Richardson MD. Tinea nigra secondary to Exophiala werneckii responding to itraconazole. Br J Dermatol 1997;137:483-4.
33. Carr JF, Lewis CW. Tinea nigra palmaris: treatment with thiabendazole topically. Arch Dermatol 1975; 111:904-5.
34. Sayegh-Carreño R, Abramovits-Ackerman W, Gión GP. Therapy of tinea nigra plantaris. Pharmacol Ther 1989;28:47-8.
35. Burke WA. Tinea nigra: treatment with topical ketoconazole. Cutis 1993;52:209-11.
36. Smith JD, Murtishaw WA, McBride ME. White piedra (Trichosporosis). Arch Dermatol 1973;107:439-42.
37. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK. Guidelines of care for superficial mycotic infections of the skin: piedra. J Am Acad Dermatol 1996;34:122-4.
38. Figueras MJ, Guarro J, Zaro L. New findings in black piedra infection. Br J Dermatol 1996;135:157.
39. Coimbra Jr. CEA, Santos RV. Black piedra among the Zoró Indians from Amazônia (Brazil). Mycopathologia 1989;107:57-60.
40. Kwon-Chung KJ, Bennett JE. Piedra. In: Cann C, Colaiezzi T, Hunsberger S, editors. Medical mycology. Philadelphia: Lea & Febiger; 1992. p. 183-98.
41. de Almeida Jr. HL, Rivitti EA, Jaeger RG. White piedra: ultrastructure and a new microecological aspect. Mycoses 1990;33:491-7.
42. Gold I, Sommer B, Urson S, Schewach-Millet M. White piedra. Int J Dermatol 1984;23:621-3.
43. Gip L. Black piedra: the first case treated with terbinafine (Lamisil). Br J Dermatol 1994;130(suppl 43): 26-8.
44. Benson PM, Odom RB. White piedra. Arch Dermatol 1983;119:602-4.
45. Walzam M, Leeming JG. White piedra and Trichosporon beigelii: the incidence in patients attending a clinic in genitourinary medicine. Genitourin Med 1989;16: 331-4.
46. Mostafa WZ, Al Jabre SH. White piedra in Saudi Arabia. Int J Dermatol 1992;31:501-2.